Program Overview

Master in Biomedical Engineering: Molecular and Cellular Biotherapies (MCB)

Overview

The Master in Biomedical Engineering: Molecular and Cellular Biotherapies (MCB) is a 2-year education program designed to provide students with a comprehensive understanding of bioengineering, at the crossroad of biomedical and engineering science. The program is based on an educational policy that fosters both an interdisciplinary, international perspective as well as the students' initiative.

Language and Length of Study

• Language(s) of instruction: English
• Length of study: 1 year for the M1, 1 year for the M2, full time

Partners

• Arts et Métiers
• Université Paris Sciences et Lettres (PSL)

Course Location

Almost all teachings take place in the center of Paris, mostly at Université Paris Cité, Arts et Métiers, ESPCI Paris, and Chimie Paris. Most sites are within walking distance. In some tracks, students may also attend lectures and scientific meetings outside Paris.

Degrees Awarded

• Master in Biomedical Engineering – Molecular and Cellular Biotherapies (MCB)

Entry Requirements

• M1 (one single track): Having obtained or being in the process of validating a Licence or a Bachelor’s degree (science related) or being a physiotherapist or a 4th year student in a physiotherapist school
• M2 (five tracks to choose from): Students may enter directly the 2nd year of the program under certain conditions
• Application: Online application and interview for pre-selected candidates
• Language pre-requisites: Certified C1 level in English

Course Overview

The BME PARIS master’s program combines the top-level and complementary expertise of three partners: engineering science represented by three engineering schools within PSL (Chimie Paris, ESPCI Paris, and Mines Paris) and Arts et Métiers on one hand, and biomedical and health science at Université Paris Cité, on the other hand. Teaching faculty comes mostly from the partner institutions. Guest lecturers include hospital clinicians (APHP), and researchers from other schools and universities as well as from private companies.

Specialization Tracks

The 1st year is a common path for all BME students (with individualized choices of courses according to their background). The 2nd year is intended to specialize students' capacities in dedicated engineering and biomedical tracks. Five specialization tracks are proposed, one of them being the Molecular and Cellular Biotherapies Track (MCB).

Molecular and Cellular Biotherapies Track (MCB)

The MCB track concerns two major categories of biotherapeutics applications: cell and gene therapy, and biopharmaceuticals. The aim of this track is to train students of advanced scientific level in the field of biotherapy in order to prepare for careers in academia. These students may also find opportunities in industry at the national, European, and international level, particularly in biotechnology and medical research laboratories in teaching hospitals, as well as in cell and gene therapy firms.

Skills and Competencies Developed

• Provide students with the knowledge and tools required in a wide range of the biomedical engineering field
• Foster a fruitful collaborative spirit between engineering and medical students
• Respect scientific ethics
• Design and develop scientific projects
• Implement a project, define the objectives and context, carry out and evaluate the action
• Conduct and develop scientific and technical projects
• Analyze, diagnose, and interpret the results of scientific experiments
• Know how to assess professional risks, implement specific evaluation methods
• Master specific methods and tools
• Use information and communication technologies
• Conduct information research, identify access modes, analyze relevance, explain, and transmit
• Scientific communication in English
• Working as a team: integrating, positioning, and collaborating
• Integrate into a professional environment: identify your skills and communicate them

Career Opportunities

Graduates of the Master in Biomedical Engineering: Molecular and Cellular Biotherapies (MCB) may pursue careers in academia, industry, and research institutions, both nationally and internationally, with a focus on biotherapy, biotechnology, and medical research.